Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Jones

Showing results (71-80 of 146) with videos related to

Pageof 15
Sort By:
Circulation|July 29, 2020
Effect of Evolocumab on Atherogenic Lipoproteins During the Peri- and Early Postinfarction Period: A Placebo-Controlled, Randomized TrialThorsten M Leucker, Michael J Blaha, Steven R Jones, et al.
European Journal of Preventive Cardiology|July 12, 2019
Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC studyRenato Quispe, Mohamed B Elshazly, Di Zhao, et al.
Mayo Clinic Proceedings|March 7, 2015
Maximal exercise testing variables and 10-year survival: fitness risk score derivation from the FIT ProjectHaitham M Ahmed, Mouaz H Al-Mallah, John W McEvoy, et al.
Journal of the American Heart Association|October 30, 2018
Coronary Endothelial Dysfunction Is Associated With Elevated Serum PCSK9 Levels in People With HIV Independent of Low-Density Lipoprotein CholesterolThorsten M Leucker, Robert G Weiss, Michael Schär, et al.
Lipids in Health and Disease|February 14, 2016
Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placeboPeter P Toth, Sara C Hamon, Steven R Jones, et al.
Journal of Clinical Lipidology|September 10, 2015
Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17)P Elliott Miller, Seth S Martin, Peter P Toth, et al.
Drugs|June 3, 2017
The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-AnalysisAmirhossein Sahebkar, Maria-Corina Serban, Peter Penson, et al.
Journal of Clinical Lipidology|March 6, 2023
The association between triglyceride-rich lipoproteins, circulating leukocytes, and low-grade inflammation: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)Fernando Yue Cesena, Giuliano Generoso, Raul D Santos, et al.
American Heart Journal|January 29, 2026
Low Levels of Atherogenic Lipoproteins & Incident Atherosclerotic Cardiovascular Disease: A Pooled Cohort Primary Prevention StudyKamil F Faridi, Renato Quispe, Seth S Martin, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 6, 2016
Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden deathDeeptankar DeMazumder, Worawan B Limpitikul, Miguel Dorante, et al.
Pageof 15

Showing results (71-80 of 146) with videos related to

Sort By:
Pageof 15
Circulation|July 29, 2020
Effect of Evolocumab on Atherogenic Lipoproteins During the Peri- and Early Postinfarction Period: A Placebo-Controlled, Randomized TrialThorsten M Leucker, Michael J Blaha, Steven R Jones, et al.
European Journal of Preventive Cardiology|July 12, 2019
Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC studyRenato Quispe, Mohamed B Elshazly, Di Zhao, et al.
Mayo Clinic Proceedings|March 7, 2015
Maximal exercise testing variables and 10-year survival: fitness risk score derivation from the FIT ProjectHaitham M Ahmed, Mouaz H Al-Mallah, John W McEvoy, et al.
Journal of the American Heart Association|October 30, 2018
Coronary Endothelial Dysfunction Is Associated With Elevated Serum PCSK9 Levels in People With HIV Independent of Low-Density Lipoprotein CholesterolThorsten M Leucker, Robert G Weiss, Michael Schär, et al.
Lipids in Health and Disease|February 14, 2016
Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placeboPeter P Toth, Sara C Hamon, Steven R Jones, et al.
Journal of Clinical Lipidology|September 10, 2015
Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17)P Elliott Miller, Seth S Martin, Peter P Toth, et al.
Drugs|June 3, 2017
The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-AnalysisAmirhossein Sahebkar, Maria-Corina Serban, Peter Penson, et al.
Journal of Clinical Lipidology|March 6, 2023
The association between triglyceride-rich lipoproteins, circulating leukocytes, and low-grade inflammation: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)Fernando Yue Cesena, Giuliano Generoso, Raul D Santos, et al.
American Heart Journal|January 29, 2026
Low Levels of Atherogenic Lipoproteins & Incident Atherosclerotic Cardiovascular Disease: A Pooled Cohort Primary Prevention StudyKamil F Faridi, Renato Quispe, Seth S Martin, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 6, 2016
Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden deathDeeptankar DeMazumder, Worawan B Limpitikul, Miguel Dorante, et al.
Pageof 15